SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

4565 (4565) News

Track canonical SquawkNews coverage tagged to 4565, 4565. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 4565 Asset market Sector Markets 90 days 1 Updated Aug 26, 2026, 07:37 AM UTC Open live news feed
M NBIX gets FDA IND acceptance for NBI-1117567 Phase 2 Alzheimer’s cognition Neurocrine Biosciences, Nxera Pharma’s partner, received FDA IND acceptance for a Phase 2 study of NBI-1117567 targeting Alzheimer’s cognition. EQUITY | Aug 26, 2026, 07:37 AM UTC